Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-06

Clinical Trial Update: A Study of E7080 in Subjects With Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 study of E7080 in subjects with solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • E7080 (lenvatinib)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-03-06